ATB — Antibiotice SA Cashflow Statement
0.000.00%
Last trade - 00:00- RON1.33bn
- RON1.56bn
- RON645.28m
Annual cashflow statement for Antibiotice SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Changes in Working Capital | -142 | -163 | 135 | 98.9 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 44.4 | 106 | 122 | 95.1 | — |
| Capital Expenditures | -29.1 | -39.9 | -98 | -116 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -29.1 | -39.9 | -98 | -116 | — |
| Financing Cash Flow Items | — | — | -4.09 | -4.61 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8.42 | -12.6 | -24.2 | 21.6 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.87 | 52.8 | 0.08 | 0.873 | — |